Stroke is characterized as a neurology deficit due to clinical, radiological, or pathological evidence of ischemia or hemorrhage with a vascular cause [1
]. Epidemiologically, stroke is the 2nd leading cause of mortality and the third leading contributor to serious long-term disability across the globe [2
]. About 20–25% of stroke patients are accompanied by serious disability [4
]. In China, stroke has imposed a tremendous burden on the health care system. In 2018, the death rate of cerebrovascular diseases was 0.15%, making up 1.57 million deaths across China [5
]. Recently, various initiatives have explored innovative stroke prevention strategies to improve the stroke-free survival and quality of life of stroke sufferers.
Cognitive impairment, with a prevalence ranging from 20 to 80%, has been confirmed as a comorbidity of ischemic stroke [6
]. Research has shown that cognitive impairment is among the most commonly seen factors that contributes to life disability following stroke, resulting in higher mortality, slower physical restoration, and the loss of economic and social capabilities [7
]. Although it is currently widely recognized that cognitive impairment-induced disabilities are frequent after stroke, the nature and magnitude of these impairments and the factors that determine their magnitude are unclear [9
]. Previous studies have explored the demographic and psychological variables that influence the onset of cognitive impairment after stroke and reported varied results [10
]. However, the mechanism or risk factors of cognitive impairment remain unclear due to heterogeneities in neurocognitive assessment tools, diagnostic criteria for cognitive impairment, and population characteristics, including the cognitive status before stroke onset or the cognitive evaluation intervals after stroke [12
]. The identification of novel and potentially reversible risk factors may be useful for clinicians in the prevention and treatment of acute ischemia stroke.
Recently, a growing body of literature has shown an interest in the link between OSA and cognitive impairment. OSA is characterized by repeated nocturnal episodes of partial pharyngeal narrowing (hypopnea) or complete pharyngeal closure (apnea). OSA is an independent risk factor for stroke, and may be a complication of stroke [13
]. OSA is often unrecognized in the common population and has high prevalence in stroke sufferers, which is between 30 and 96% depending on the population studied [15
]. Increasing evidence suggests that OSA may contribute to cognitive impairment in several domains, including concentration, vigilance, episode memory, work memory, and executive functioning [8
]. In the population with insomnia and sleep deprivation, OSA has been found to be negatively related to cognitie function [18
]. Fortunately, appropriate management, such as continuous positive airway pressure (CPAP) or maxillomandibular advancement devices (MADs), exerts a remarkable effect on multiple cognition domains in OSA sufferers, particularly work memory, long-term verbal memory, and short-term visual spatial memory [21
Minor ischemic stroke is generally defined as a scoring ≤ 5 as per the National Institute of Health Stroke Scale (NIHSS)[20
]. Cognitive impairments have been found in more than 80% of patients with minor stroke [26
]. To date, limited studies with diverse results have been conducted to evaluate the role of OSA in cognition damage in those patients [21
]. Most studies recruited acute stroke sufferers with different severities without thorough neural psychological or imaging evaluations [22
]. Furthermore, various severities of OSA have shown significant differences in prospective memory and sleep efficiency in stroke sufferers [24
]. The effects and mechanism of OSA of different severities on cognitive changes in patients with minor stroke remain unclear. Considering the high incidence of OSA and its potential contribution to morbidity and mortality among patients with stroke, we conducted this study to assess the role of OSA in cognition damage in sufferers with minor ischemic stroke.
Study design and participants
The present research’s procedures were approved by the university’s Ethical Board. Every patient offered informed written consent. Patients with ischemia stroke admitted to the Neural Psychiatric Disorders and Mental Health Centre of Anhui Province between January 2020 and May 2021 were invited to participate in our study. The inclusive criteria were as follows: (1) 18 to 75 years of age; (2) ischemic stroke proven via computed tomography (CT) and/or magnetic resonance imaging (MRI) and diagnosed by a neurologist; (3) NIHSS score between 1 and 5 at admission, defined as minor ischemic stroke; and (4) admission between 1 and 7 days after stroke onset.
Patients were excluded if they had (1) serious medical conditions, including respiratory failure and advanced CHF; (2) a history of any cognition impairment or psychiatric comorbidity before the stroke; (3) central sleep apnea, complex sleep apnea, or previously diagnosed OSA; or (4) refusal to participate in all testing. Data on demographic and clinical characteristics, including medical history, medications, and stroke details, were collected. Overnight polysomnography (PSG) was conducted to assess for OSA, and a set of neuropsychological assessments was conducted to evaluate cognitive function.
Sleepiness was assessed using the Epworth Sleepiness Scale (ESS) before performing PSG. Each stroke sufferer received PSG using the Alice 6 Diagnosis Platform, Respironics, America for one night at the sleep lab in our department. PSG was conducted over 8 h within 7 days of stroke onset. The parameters investigated included airflow (sensed by both thermistor and pressure transducer), six electroencephalographic leads (F3, F4, C3, C4, O1, and O2), electrooculographic, electrocardiographic, electromyographic (chin and leg muscles) measurements, thoracoabdominal respiratory effort, snoring, body position, blood oxygen saturation, and pulse rate.
Apnea was defined as air flow cessation ≥ 90% lasting for ≥ 10 s. Apnea with ongoing chest and abdomen effort, no chest and abdomen movements, and with initial lack of motion followed by respiratory effort were categorized as obstructive, central, and mixed apneas. Hypopnea was defined as a reduction in air flow or a reduction of thoracic and abdominal movement amplitude of 50% for ≥ 10 s with an oxygen desaturation ≥ 3%. The apnea hypopnea index (AHI) was the average of apneas and hypopneas per hour of sleep. The clinical diagnosis of OSA was made in patients with an AHI ≥ 5 by PSG [25
]. The sufferers were grouped into the no OSA group (AHI < 5), which served as the control group in this research, mild OSA group (AHI 5–15), and moderate-to-severe OSA (MS OSA) group (AHI ≥ 15).
The PSG parameters of sleep structure variables (arousal index, sleep efficiency, total sleep time (TST), proportion (%) of sleep duration in stage 3 sleep, and proportion (%) of sleep duration in the rapid eye movement (REM) stage) and hypoxia and disordered breathing (proportion (%) of nighttime spent with an oxyhemoglobin saturation < 90% (TSat90), lowest SpO2, average SpO2, and oxygen desaturation index (ODI)) of all patients were collected.
Every patient ompleted a set of standardized neuropsychology assessments to evaluate global cognition and clinical symptoms within 7 days after stroke. All tests were carried out in a quiet and separate room outside the stroke unit. These assessments included the following:
the CAVLT was utilized to assess functions of memory, including instantaneous memory, delayed memory, and recognition memory functions;
the Digital Span Test (DST), which includes forward and backward tests, used as a tool for investigating verbal attention and working memory;
the Montreal Cognitive Assessment (MoCA) was utilized to assess multiple cognition domains, such as short-term memory, attention and work memory, visual spatial capability, executive function, concentration, linguistic skill, and spatiotemporal orientation;
the Hamilton Anxiety Rating Scale (HAMA) was used to evaluate the severity of depressive symptoms;
the Hamilton Rating Scale for Depression (HAMD) was used to evaluate anxiety; and
the Stroop Color Word Test (SCWT), which comprises the Stroop color, word, and interference tests, was employed to evaluate executive function.
All data were analyzed via SPSS 23.0 (America). Standard descriptive statistics were used to summarize the clinical characteristics and sleep and cognitive assessments of all participants. The differences in the clinical characteristics, polysomnography parameters, and cognitive assessment among the 3 groups were analyzed via ANOVA. The post hoc (LSD) tests for multiple comparisons were also performed to compare the difference of polysomnography parameters and cognitive functions among the 3 groups. A binary logistic regression analysis with the “enter” approach was utilized to forecast OSA on the foundation of the AHI and potential predictors. Furthermore, the patients were classified into two groups that exhibit cognition damage (MoCA < 26) and normal cognition function (MoCA ≥ 26). The polysomnography predictor of cognitive impairment based on MoCA in stroke patients was also evaluated by a logistic regression analysis with adjustments for confounding covariates. p < 0.05 was used to signify statistical significance.
OSA is a commonly seen comorbidity in stroke sufferers that reportedly exaggerates cognition damage [31
]. In this study, there was a high prevalence of stroke survivors suffering from OSA (63% (59/94)), which is consistent with the outcomes of past research [28
]. Hypertension and smoking were ommon in the mild and medium-to-serious OSA groups more frequently compared to the no OSA group. This finding was expected as both factors are known risk factors for OSA [34
]. Compared with the patients without OSA, the OSA sufferers demonstrated a greater prevalence of hypoxia and disordered breathing, including arousal index, SpO2, ODI, sleep efficiency, and TSat90 (p
< 0.001). Lower cognitive performance (including the CAVLT, DST, MoCA, and SCWT) was also identified in the sufferers with mild and medium-to-serious OSA in contrast to the sufferers with no OSA. The regression analysis revealed a link among MoCA, lower AHI values, and the lowest SpO2 (p
< 0.05). Cognitive impairment was not associated with the other clinical characteristics, such as stroke type or classification, which is consistent with previous studies [27
A primary finding of this study is that OSA is linked to a poorer neurological status, including memory and executive function, at the time of admission in patients with ischemia stroke. Those discoveries are backed by past research that showed that OSA was related to an impaired functional status at discharge and 3 and 12 months following stroke [26
]. However, some results did not completely coincide with past research. Zhang et al. [29
] also showed that time- and event-based prospective memory was damaged independently by OSA in stroke sufferers. Slonkova et al. [28
] demonstrated poorer memory in the OSA group in contrast to the no OSA group of stroke patients. Aaronson et al. [27
] discovered that OSA sufferers following stroke presented inferior results in examinations of concentration, executive function, visual perception, psychomotor capability, and intelligence in contrast to the sufferers with no OSA, while no differences were seen in memory between the sufferers in the 2 groups. These differences might be explained by the neuropsychology assessments conducted at different times (4 weeks vs. 3 and 12 months after admission), and different neuropsychologic tools. On the contrary, Kaneko et al. [35
] did not see differences in the neurological status (measured with the Canadian Neurological Scale) between stroke sufferers in the presence and absence of OSA upon admission to a stroke rehabilitation unit, even though a slightly lower score was found in the patients with OSA. The small size of the no OSA group might have accounted for these results.
To date, most research exploring the association between sleep disorders and decreased cognition have focused on sleep apnea after stroke, and studies investigating the association between sleep duration and architecture and decreased cognition after stroke are insufficient [36
]. Our team explored the potential pathophysiological mechanisms mediating OSA-associated cognitive impairment by analyzing the sleep time and structure in stroke patients. Our results revealed a higher occurrence of sleep disorders, including both airflow of respiratory tracts (arousal index, AHI, and ODI) and blood oxygen levels (SpO2 and TSat90), and lower sleep efficiency in the patients with mild and medium-to-severe OSA compared with the patients with no OSA in our experiments [37
]. The logistic regressive analyses further revealed that the AHI and lowest SpO2 were the most important risk factors for cognition damage based on the MoCA.
Certain limitations of our research deserve disclosure. First, the cross-sectional research design prevented causal inference between cognitive impairment and OSA in patients with stroke. Prospective cohort study is necessary in future investigations. Second, the sample size of our study was relatively small, which affects the conclusions. More research based on a bigger sample size are warranted. Third, there were deviations in the prevalence of hypertension and smoking status in the stroke sufferers in the presence and absence of OSA, and these differences may have affected the comparison of the polysomnography and neuropsychology assessments among the groups.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.